Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Anxiety Disorders

Trial Information

Safety, Efficacy and Tolerability of Vilazodone in Generalized Anxiety Disorder

Official Title: A Double-blind, Placebo-Controlled Fixed-Dose Study of Vilazodone in Patients With Generalized Anxiety Disorder.

Summary

The purpose of this study is to evaluate the efficacy, safety and tolerability of vilazodone relative to placebo in the treatment of generalized anxiety disorder (GAD)

Phase: Phase 3

Sponsor: Forest Laboratories

Overall Contacts:

Sandra Beaird, PhD
1-800-678-1605 ext. 66297

Locations (30)

Country State City Zip Facility and Contact
United States Alabama Birmingham 35216 Forest Investigative Site 001
United States California Glendale 91204 Forest Investigative Site 023
United States Connecticut Norwich 06360 Forest Investigative Site 026
United States Connecticut Waterbury 06708 Forest Investigative Site 027
United States Florida Delray Beach 33484 Forest Investigative Site 005
United States Florida Oakland Park 33334 Forest Investigative Site 014
United States Florida South Miami 33143 Forest Investigative Site 019
United States Georgia Decatur 30030 Forest Investigative Site 035
United States Illinois Chicago 60634 Forest Investigative Site 028
United States Illinois Schaumburg 60194 Forest Investigative Site 030
United States Kansas Topeka 66606 Forest Investigative Site 029
United States Kansas Wichita 67207 Forest Investigative Site 033
United States Louisiana Lake Charles 70629 Forest Investigative Site 010
United States Massachusetts Boston 02114 Forest Investigative Site 025
United States Missouri St. Louis 63104 Forest Investigative Site 037
United States New Jersey Berlin 08009 Forest Investigative Site 016
United States New York New York 10168 Forest Investigative Site 012
United States New York New York 10003 Forest Investigative Site 024
United States New York New York 10023 Forest Investigative Site 032
United States North Dakota Bismarck 58501 Forest Investigative Site 020
United States Ohio Cincinnati 45215 Forest Investigative Site 008
United States Ohio Dayton 45414 Forest Investigative Site 041
United States Oklahoma Oklahoma City 73112 Forest Investigative Site 004
United States Oklahoma Oklahoma City 73116 Forest Investigative Site 034
United States Tennessee Memphis 38119 Forest Investigative Site 006
United States Texas Wichita Falls 76309 Forest Investigative Site 017
United States Utah Salt lake City 84106 Forest Investigative Site 003
United States Virginia Charlottesville 22911 Forest Investigative Site 018
United States Washington Bellevue 98007 Forest Investigative Site 040
United States Washington Seattle 98104 Forest Investigative Site 039

NCT ID:NCT01629966

Date Last Changed: April 15, 2013